70 likes | 177 Views
Asthma is a chronic inflammatory lung disease that affects persons of all ages, but most commonly starts in childhood. It is a common long-term condition characterized by narrowing of the airways, leading to airflow limitation and airway hyper-responsiveness whenever the lungs come into contact with endogenous and exogenous irritants. Exposure to irritants instigates a series of events, such as swelling of the airways, tightening of the respiratory muscles, and increased mucus production, leading to reduced airflow into the lungs. To Read Complete Report with Toc: http://www.marketresearchreports.biz/analysis/223222
E N D
EpiCast Report:Asthma-EpidemiologyForecastTo2023 Asthma persons isachronicinflammatorylungdiseasethataffects ofallages,butmostcommonlystartsinchildhood. Itisacommonlong-termconditioncharacterizedby narrowingoftheairways,leadingtoairflowlimitationandairwayhyper-responsivenesswheneverthelungscomeinto
contactwithendogenousandexogenousirritants.Exposureto irritantsinstigatesaseriesofevents,suchasswellingoftheairways,tighteningoftherespiratorymuscles,andincreasedmucusproduction,leadingtoreducedairflowintothelungs. ToReadCompleteReportwithToc: http://www.marketresearchreports.biz/analysis/223222 In2013,therewere137.66millionlifetimeprevalentcasesof asthmainthe10MM,with82.71millioncasesintheUS(43.16millioncases)andIndia(39.55millioncases)combined.GlobalDataepidemiologistsforecastthattherewillbeapproximately161.02millionlifetimeprevalentcasesof
asthmainthe10MMby2023,withanoverallgrowthof 17.0%overthenextdecade. GlobalDataepidemiologistsforecasttheprevalentcasesof asthmainthe10MMfrom2013-2023usingcountry-specific studiespublishedinpeer-reviewed age-andsex-specificprevalenceofmarkets.Theepidemiologistsmadenationally-representativestudiesin journalsthatprovidedthe asthmaintherespectivesurethatalltheselectedtherespectivecountries assessedthelifetimeasthmaprevalenceusingthesamestudy definition,therebyensuringthattheresultsforecastforeachcountryarecomparable.Inaddition,thelifetimeprevalentcasesofasthmaineachcountrywerefurthersegmentedbyasthmaseveritybasedontheGlobalInitiativeforAsthma
guidelines.Theforecastmethodologywasconsistentacrossall the10MMtoallowforameaningfulcomparisonamongthem. BrowseFullReportWithToc: http://www.marketresearchreports.biz/analysis-details/epicast-report-asthma-epidemiology-forecast-to-2023 Scope -TheAsthmaEpiCastReportprovidesanoverviewofthe riskfactors,comorbidities,andglobaltrendsforasthmain thetenmajormarkets(10MM)(US,France,Germany,Italy, Spain,UK,Japan,Australia,China,andIndia).Itincludesa 10-yearepidemiologicalforecastofthelifetimeprevalent
casesofasthmasegmentedbysex,age(infive-year incrementsbeginningat0yearsandendingat=85years), andasthmaseverityinthesemarkets. -TheAsthmaepidemiologyreportiswrittenanddeveloped byMasters-andPhD-levelepidemiologists. -TheEpiCastReportisin-depth,highquality,transparent andmarket-driven,providingexpertanalysisofdiseasetrendsinthe10MM. ClickHereToDownloadDetailReport: http://www.marketresearchreports.biz/sample/sample/223222
Reasonstobuy -Developbusinessstrategiesbyunderstandingthetrends shapinganddrivingtheglobalAsthmamarket. -QuantifypatientpopulationsintheglobalAsthmamarkettoimproveproductdesign,pricing,andlaunchplans. -Organizesalesand andagegroupsthattherapeuticsineach marketingeffortsbyidentifyingthesex presentthebestopportunitiesforAsthmaofthemarketscovered.
ContactUS: Office:UnitedStates StateTower 90StateStreet,Suite700 Albany,NY12207 UnitedStates TollFree:866-997-4948 Tel:+1-518-618-1030 E:sales@marketresearchreports.biz